Companies across disparate sectors are aggressively restructuring their portfolios in the second half of 2026, pivoting toward artificial intelligence infrastructure and core logistics while divesting legacy assets, according to regulatory filings and people familiar with the matter.

Tech Pivots and Defense Expansion

Smartbird Inc. (BIRD.US) is targeting an aggressive corporate pivot. The former eco-footwear brand sold its legacy shoe assets for roughly USD 43M in June 2026, shifting focus entirely to AI infrastructure-as-a-service for healthcare and finance. The company reported quarterly revenue of USD 22.3M alongside a net loss of USD 20.7M, while doubling its convertible financing facility to USD 100M.

In the defense edge-computing space, One Stop Systems Inc. (OSS.US) raised its full-year revenue growth forecast to 25% to 30%. The company posted Q2 2026 revenue of USD 9.3M, up 62.3% year-over-year, and booked a historic USD 15.1M in orders. A new US Department of Defense intelligence platform contract is expected to generate USD 44M over the next four years.

Skycorp Solar Group Limited (PN.US) is similarly expanding its high-performance computing and solar PV footprint. The company agreed to acquire the remaining 56% stake in Nanjing Cesun Power and closed recent PIPE financings totaling USD 6.6M, sending shares surging over 71% overnight. FY25 total revenue stood at USD 63.3M.

Electric aerospace firm Beta Technologies Inc. (BETA.US) is nearing a deal to expand its financing relationship with the US EXIM Bank by up to USD 1B. After the announcement and news that Lockheed Martin's Sikorsky will integrate its autonomous suite into Beta's aircraft, shares outperformed. Order backlog has grown to USD 3.9B.

Healthcare and Commercialization

Generate Biomedicines Inc. (GENB.US) is advancing its generative biology pipeline following a USD 400M IPO in February 2026. The company is advancing Phase 3 clinical trials for its respiratory asset GB-0895, with potential milestone payments from strategic partners Amgen and Novartis reaching up to USD 2.9B.

Life sciences giant Agilent Technologies Inc. (A.US) gained ground in pre-market trading after its PD-L1 companion diagnostics secured critical approvals in the EU and US for specific cancers in July 2026. The company previously generated USD 6.95B in FY25 revenue.

Logistics and Asset Divestitures

Trans-Pacific logistics demand continues to bolster ocean freight earnings. Matson Inc. (MATX.US) reported Q2 2026 net income of USD 129.4M as total revenue jumped 16.7% to USD 969.4M. Driven by strong China service demand, the company raised its guidance, expecting Q3 ocean transportation operating income to track 45% higher than the USD 147.4M posted a year ago.

Greek tanker operator Rubico Inc. (RUBI.US) is moving to divest non-core assets. The company exited the superyacht sector to re-deploy capital into its core oil tankers. The acquisition of a third newly built MR tanker boosted its potential revenue backlog by 24% to USD 379M, with management-estimated NAV climbing 94% to USD 183.1M.

Consumer and Proptech Rationalization

The Campbells Company (CPB.US) is preparing to make "tough decisions" regarding its snack portfolio. Despite a 4% year-over-year rise in Q3 net sales, organic growth in the snacks division fell 4%. Executives cited a pullback in consumer demand as the catalyst for the potential portfolio rationalization.

Singapore proptech firm Ohmyhome Limited (OMH.US) executed a deep restructuring, selling its core real estate business for a nominal USD 1 in June 2026 and forgiving USD 19M in subsidiary debt. Despite Q3 brokerage transaction volumes hitting USD 84M, the company was flagged by Nasdaq for failing to meet minimum bid price requirements, prompting a USD 4M registered direct offering.

This article does not constitute investment advice.